Epstein Barr virus: development of vaccines and immune cell therapy for EBV-associated diseases
X Cui, CM Snapper - Frontiers in Immunology, 2021 - frontiersin.org
Epstein-Barr virus (EBV) is the first human tumor virus discovered and is strongly implicated
in the etiology of multiple lymphoid and epithelial cancers. Each year EBV associated …
in the etiology of multiple lymphoid and epithelial cancers. Each year EBV associated …
mRNA vaccines: The future of prevention of viral infections?
Messenger RNA (mRNA) vaccines against COVID‐19 are the first authorized biological
preparations developed using this platform. During the pandemic, their administration has …
preparations developed using this platform. During the pandemic, their administration has …
EBV-associated diseases: Current therapeutics and emerging technologies
EBV is a prevalent virus, infecting> 90% of the world's population. This is an oncogenic virus
that causes~ 200,000 cancer-related deaths annually. It is, in addition, a significant …
that causes~ 200,000 cancer-related deaths annually. It is, in addition, a significant …
Urgency and necessity of Epstein-Barr virus prophylactic vaccines
Abstract Epstein-Barr virus (EBV), a γ-herpesvirus, is the first identified oncogenic virus,
which establishes permanent infection in humans. EBV causes infectious mononucleosis …
which establishes permanent infection in humans. EBV causes infectious mononucleosis …
Epstein-Barr virus is present in the brain of most cases of multiple sclerosis and may engage more than just B cells
Multiple sclerosis (MS) is a chronic neuroinflammatory condition of the central nervous
system (CNS). It is a major cause of neurological disability in young adults, particularly …
system (CNS). It is a major cause of neurological disability in young adults, particularly …
Vaccine development for Epstein-Barr virus
JI Cohen - Human Herpesviruses, 2018 - Springer
Epstein-Barr virus (EBV) is the primary cause of infectious mononucleosis and is associated
with several malignancies, including nasopharyngeal carcinoma, gastric carcinoma …
with several malignancies, including nasopharyngeal carcinoma, gastric carcinoma …
The potential for EBV vaccines to prevent multiple sclerosis
There is increasing evidence suggesting that Epstein-Barr virus infection is a causative
factor of multiple sclerosis (MS). Epstein-Barr virus (EBV) is a human herpesvirus, Human …
factor of multiple sclerosis (MS). Epstein-Barr virus (EBV) is a human herpesvirus, Human …
Progress in EBV vaccines
DG Van Zyl, J Mautner, HJ Delecluse - Frontiers in oncology, 2019 - frontiersin.org
The Epstein-Barr virus (EBV) is a ubiquitous pathogen that imparts a significant burden of
disease on the human population. EBV is the primary cause of infectious mononucleosis …
disease on the human population. EBV is the primary cause of infectious mononucleosis …
[HTML][HTML] T cell-mediated immunity during Epstein–Barr virus infections in children
M Liu, R Wang, Z **e - Infection, Genetics and Evolution, 2023 - Elsevier
Epstein–Barr virus (EBV) infection is extremely common worldwide, with approximately 90%
of adults testing positive for EBV antibodies. Human are susceptible to EBV infection, and …
of adults testing positive for EBV antibodies. Human are susceptible to EBV infection, and …
The promise of a prophylactic Epstein–Barr virus vaccine
The worldwide burden of disease due to Epstein–Barr virus (EBV) infection is enormous.
Diseases include endemic Burkitt lymphoma, infectious mononucleosis, cancers after …
Diseases include endemic Burkitt lymphoma, infectious mononucleosis, cancers after …